A good product evolves and carries its success into new markets, new indications, new populations, and new dosage forms. Even before filing for regulatory approval the planning should begin for the product's life after approval. After the tumult of a launch, it is easy to relax but new threats are already gathering. Protect your intellectual property and market exclusivity as long as possible through targeted product innovation and evolution.

For drugs there are many channels to extending economic life:

    --505(b)2 - earn another three years of exclusivity through calculated product enhancements.
    --Combination products - enhance patient convenience and compliance with combined therapies.
    --Special Populations - race, gender, geriatric, pediatric, special disease populations.
    --Dosage Forms - improve the route of administration or dosage frequency.
    --Safety/Efficacy Improvements
    --Pricing Planning
    --Generic Competitor Strategy and Planning
    --OTC Strategy and Planning

We can help you evaluate the options and set a course for continuing your product's success.